Below are the most recent publications written about "Benzylamines" by people in Profiles.
-
Hegde SM, Lester SJ, Solomon SD, Michels M, Elliott PM, Nagueh SF, Choudhury L, Zemanek D, Zwas DR, Jacoby D, Wang A, Ho CY, Li W, Sehnert AJ, Olivotto I, Abraham TP. Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2021 12 21; 78(25):2518-2532.
-
Soni C, Schell SL, Fasnacht MJ, Chodisetti SB, Rahman ZS. Crucial role of Mer tyrosine kinase in the maintenance of SIGN-R1+ marginal zone macrophages. Immunol Cell Biol. 2018 03; 96(3):298-315.
-
Wohlfarth A, Roman M, Andersson M, Kugelberg FC, Diao X, Carlier J, Eriksson C, Wu X, Konradsson P, Josefsson M, Huestis MA, Kronstrand R. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal. 2017 May; 9(5):680-698.
-
Tolar J, McGrath JA. Augmentation of cutaneous wound healing by pharmacologic mobilization of endogenous bone marrow stem cells. J Invest Dermatol. 2014 Sep; 134(9):2312-2314.
-
Kowey PR, Mudumbi RV, Aquilina JW, DiBattiste PM. Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs R D. 2011; 11(1):1-11.
-
Nagarakanti R, Sodhi S, Lee R, Ezekowitz M. Chronic antithrombotic therapy in post-myocardial infarction patients. Cardiol Clin. 2008 May; 26(2):277-88, vii.
-
Hu A, Jiao X, Gao E, Li Y, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ. Tonic beta-adrenergic drive provokes proinflammatory and proapoptotic changes in aging mouse heart. Rejuvenation Res. 2008 Feb; 11(1):215-26.
-
Ford GA, Choy AM, Deedwania P, Karalis DG, Lindholm CJ, Pluta W, Frison L, Olsson SB. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials. Stroke. 2007 Nov; 38(11):2965-71.
-
Lotke PA, Callaghan JJ, Dorr LD, Engh GH, Hanssen AD, Healy WL, Lachiewicz PF, Lonner JH, Nelson C, Ranawat CS, Ritter MA, Salvati EA, Sculco TP, Thornhill TS. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2006 May; 88(5):1163; author reply 1163-5.
-
Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Arch Intern Med. 2006 Apr 24; 166(8):853-9.